The use of aromatase inhibitors in infertility and gynecology

Jana Al-Shalati, Togas Tulandi
In: Expert Review of Obstetrics & Gynecology · 2011 · vol. 6(4) , pp. 415–421 · doi:10.1586/eog.11.30 · W2124542169
article OA: bronze CC0
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Aromatase inhibitors block estrogen production and are used for ovulation induction, controlled ovarian hyperstimulation, and treating estrogen-dependent conditions like endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Aromatase inhibitors act by blocking the aromatization of androgen to estrogen. Although the concentration of estrogen is decreased, they do not have the antiestrogen effect of clomiphene. This makes them ideal for ovulation induction and controlled ovarian hyperstimulation. Owing to their ability to decrease estrogen concentration, aromatase inhibitors could also be used for estrogen-dependent conditions including endometriosis, myoma and adenomyosis. In addition, they could be useful for stimulation of follicle development in women with estrogen-dependent neoplasia who wish to preserve their fertility.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (40)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK